Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06912776 · ClinicalTrials.gov registry record · NA

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

A NA study of Postpartum, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06912776: Recruiting NA study of Postpartum, sponsored by Northwestern University.

NCT06912776 is a NA study of Postpartum that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 40 participants, below the 248-participant average among 16 other Postpartum trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06912776, a NA study of Postpartum, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy while remaining simplistic for patients of varying levels of health care literacy. The investigative team will be focusing on urgent warning signs pertinent to the postpartum period.

Primary Outcome

Participant will accurately identify the health care issue shown to participants and identified as Picture A and Picture B

Conditions Studied

Interventions

  • OTHER Participant will view a visual aid picture (appendix A) first
  • OTHER Participant will view a visual aid picture (appendix B) first

Study Locations (1)

Illinois

  • Northwestern Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-20
Est. Completion 2026-08
Phase NA
Northwestern University

1,209 total trials

What NCT06912776 shows while recruiting

NCT06912776 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 248-participant average among 16 other Postpartum trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Postpartum appearing as the primary indexed condition, and to 2 interventions - of which Participant will view a visual aid picture (appendix A) first is the first listed.

NCT06912776 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06912776 about?

NCT06912776 is a clinical study titled "Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs". This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy ...

What is the current status of trial NCT06912776?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-20. Estimated completion is 2026-08.

What conditions does trial NCT06912776 study?

This clinical trial studies the following conditions: Postpartum.

What interventions are being tested in trial NCT06912776?

The interventions under investigation include: Participant will view a visual aid picture (appendix A) first (OTHER), Participant will view a visual aid picture (appendix B) first (OTHER).

Who is sponsoring clinical trial NCT06912776?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06912776 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06912776's enrollment target sits among peer trials

40 14th of 16 higher than 2 of 16 other Postpartum trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06912776, the US trial registry maintained by the National Library of Medicine. NCT06912776 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.